Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
United States | 15.3 | 18.1 | 18.7 | 0.0 | 21.2 | 21.5 | 22.7 | 20.4 |
Asia | 5.0 | 9.3 | 7.7 | 7.8 | 7.4 | 8.3 | 8.8 | 6.5 |
Europe and Middle East | 6.3 | 6.7 | 7.2 | 5.7 | 4.5 | 4.7 | 4.8 | 7.6 |
Other | 0.8 | 1.0 | 1.1 | 1.6 | 1.5 | 1.5 | 1.7 | 2.0 |
Other | | | | 19.7 | | | | |
Total revenues [+] | 27.5 | 35.2 | 34.8 | 34.8 | 34.5 | 36.0 | 38.0 | 36.5 |
Products | | | | | | | 16.2 | 15.9 |
Services | | | | | | | 21.7 | 20.2 |
Other | | | | | | | | 0.4 |
Revenue growth [+] | -21.9% | 1.2% | -0.1% | 0.7% | -4.0% | -5.2% | 4.2% | 1.8% |
United States | -15.5% | -3.2% | 94991.5% | -99.9% | -1.5% | -5.3% | 11.2% | -8.0% |
Asia | -45.9% | 20.4% | -1.4% | 5.4% | -10.3% | -5.6% | 34.4% | 12.1% |
Europe and Middle East | -5.8% | -7.1% | 26.7% | 27.6% | -5.0% | -2.5% | -36.2% | 17.8% |
Other | -23.7% | -4.6% | -30.8% | 4.6% | -2.9% | -8.8% | -13.6% | 39.8% |
Cost of goods sold [+] | 8.7 | 10.3 | 9.6 | 9.3 | 9.7 | 9.9 | 10.0 | 10.6 |
Cost of product sales | | | | | | | 6.5 | 7.4 |
Cost of services | | | | | | | 3.5 | 3.2 |
Gross profit | 18.8 | 24.9 | 25.1 | 25.5 | 24.9 | 26.1 | 28.0 | 25.8 |
Gross margin | 68.5% | 70.7% | 72.3% | 73.3% | 72.0% | 72.6% | 73.7% | 70.8% |
Selling, general and administrative [+] | 18.2 | 16.8 | 18.1 | 20.7 | 22.0 | 22.9 | 23.4 | 23.7 |
Sales and marketing | 12.3 | 12.0 | 13.0 | 14.7 | 15.6 | 16.9 | 17.8 | 18.0 |
General and administrative | 5.9 | 4.9 | 5.1 | 5.9 | 6.4 | 5.9 | 5.6 | 5.6 |
Research and development | 7.5 | 7.2 | 6.3 | 7.4 | 7.1 | 7.2 | 6.8 | 6.3 |
Equity in earnings | | | | | | | | |
EBITDA [+] | -5.6 | 2.1 | 1.6 | -1.5 | -2.5 | -2.0 | -0.1 | -1.8 |
EBITDA growth | -371.4% | 27.4% | -205.7% | -38.3% | 25.7% | 2690.1% | -96.1% | 93.8% |
EBITDA margin | -20.5% | 5.9% | 4.7% | -4.4% | -7.2% | -5.5% | -0.2% | -5.0% |
Depreciation | 1.3 | 1.2 | 0.7 | 0.7 | 1.4 | 1.4 | 1.6 | 1.6 |
EBITA | -6.9 | 0.9 | 1.0 | -2.2 | -3.9 | -3.4 | -1.6 | -3.4 |
EBITA margin | -25.1% | 2.4% | 2.8% | -6.3% | -11.3% | -9.5% | -4.3% | -9.4% |
Amortization of intangibles | 0.0 | 0.0 | 0.2 | 0.3 | 0.3 | 0.6 | 0.7 | 0.7 |
EBIT [+] | -6.9 | 0.8 | 0.7 | -2.5 | -4.2 | -4.0 | -2.3 | -4.1 |
EBIT growth | -957.9% | 9.6% | -129.3% | -40.7% | 6.9% | 73.9% | -44.4% | 55.6% |
EBIT margin | -25.2% | 2.3% | 2.1% | -7.2% | -12.2% | -11.0% | -6.0% | -11.2% |
Non-recurring items [+] | | | | | 11.8 | 0.6 | | |
Asset impairment | | | | | 11.8 | 0.6 | | |
Interest expense | 0.0 | 0.0 | 0.7 | 0.9 | 0.6 | 0.5 | 0.6 | 0.4 |
Interest expense | 0.0 | 0.0 | 0.7 | 0.9 | 0.6 | 0.5 | 0.6 | 0.4 |
Other income (expense), net [+] | -0.4 | 2.3 | -0.1 | -0.1 | 0.1 | -0.1 | -0.2 | 0.0 |
Gain (loss) on debt retirement | | 2.3 | | | | | | |
Other | -0.4 | 0.0 | -0.1 | -0.1 | 0.1 | -0.1 | -0.2 | 0.0 |
Pre-tax income | -7.3 | 3.1 | 0.0 | -3.5 | -16.5 | -5.1 | -3.0 | -4.4 |
Income taxes | -0.2 | 0.0 | 0.1 | 0.1 | -4.3 | -0.1 | 0.3 | 0.1 |
Tax rate | 3.2% | 0.5% | | | 26.3% | 1.5% | | |
Net income | -7.1 | 3.1 | -0.2 | -3.7 | -12.4 | -5.2 | -3.3 | -4.5 |
Net margin | -25.8% | 8.7% | -0.5% | -10.7% | -36.0% | -14.5% | -8.7% | -12.4% |
|
Basic EPS [+] | ($0.72) | $0.37 | ($0.02) | ($0.64) | ($2.67) | ($1.17) | ($0.76) | ($1.04) |
Growth | -291.4% | -1607.2% | -96.1% | -76.0% | 127.3% | 55.3% | -27.6% | 54.8% |
Diluted EPS [+] | ($0.72) | $0.36 | ($0.02) | ($0.64) | ($2.67) | ($1.17) | ($0.76) | ($1.04) |
Growth | -301.1% | -1534.0% | -96.1% | -76.0% | 127.3% | 55.3% | -27.6% | 54.8% |
|
Shares outstanding (basic) [+] | 9.9 | 8.2 | 7.2 | 5.8 | 4.7 | 4.4 | 4.4 | 4.3 |
Growth | 20.3% | 14.1% | 23.7% | 25.3% | 4.9% | 1.1% | 1.3% | 3.8% |
Shares outstanding (diluted) [+] | 9.9 | 8.7 | 7.2 | 5.8 | 4.7 | 4.4 | 4.4 | 4.3 |
Growth | 14.4% | 19.9% | 23.7% | 25.3% | 4.9% | 1.1% | 1.3% | 3.8% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|